Triangle Pharmaceuticals: Clinical Trials

4 trials sponsored by Triangle Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 suspended, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Suspended 1, Unknown 1

Follow Triangle Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART
emtricitabine, FTC (drug), didanosine, ddI (drug), efavirenz (drug) - HIV Infections
Phase 3CompletedANRS, Emerging Infectious Diseases3502001-04-012026-06-15
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
Efavirenz, Emtricitabine, Stavudine - HIV Infections
Phase 3UnknownTriangle Pharmaceuticals2000-08-012005-06-24
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Abacavir sulfate, Efavirenz, Emtricitabine - HIV Infections
Phase 3SuspendedTriangle Pharmaceuticals1999-08-012005-06-24
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
Emtricitabine, Lamivudine - HIV Infections
Phase 3CompletedTriangle Pharmaceuticals3902005-06-24

Conditions studied

HIV Infections (4)

Interventions

Emtricitabine (4)  ·  efavirenz (3)  ·  Didanosine (2)  ·  Stavudine (2)  ·  Lamivudine (1)  ·  Pharmaceutical Preparations (1)  ·  Racivir (1)  ·  abacavir (1)

Countries

United States (3)  ·  Argentina (1)  ·  Canada (1)  ·  Chile (1)  ·  France (1)  ·  Mexico (1)  ·  Puerto Rico (1)

Top investigators

Charles van der Horst (1)  ·  Genevieve Chene, MD, PhD (1)  ·  Jean-Michel Molina, MD, PhD (1)

Results publications

PMID 15717256, PMID 21036772